Mutation analysis of the HIF-1α oxygen-dependent degradation domain in invasive breast cancer

Cancer Genetics and Cytogenetics

Volumn 163, Issue 2, 2005, Pages 168-172

  Vleugel, Marije M ^a   Greijer, Astrid E ^b   Van Der Wall, Elsken ^a   Van Diest, Paul J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; GENE ORDER; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SAMPLE; SEQUENCE ANALYSIS; TUMOR; WILD TYPE;

BASE SEQUENCE; BREAST NEOPLASMS; DNA PRIMERS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MUTATION; NEOPLASM INVASIVENESS; OXYGEN; POLYMERASE CHAIN REACTION;

EID: 28744451386     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.05.008     Document Type: Article

References (33)

1. B.H. Jiang, E. Rue, G.L. Wang, R. Roe, and G.L. Semenza Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1 J Biol Chem 271 1996 17771 17778
2. G.L. Semenza HIF-1: mediator of physiological and pathophysiological responses to hypoxia J Appl Physiol 88 2000 1474 1480
3. G.L. Semenza, and G.L. Wang A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation Mol Cell Biol 12 1992 5447 5454
4. L.E. Huang, Z. Arany, D.M. Livingston, and H.F. Bunn Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit J Biol Chem 271 1996 32253 32259
5. 2 tension Am J Physiol 271 4 Pt 1 1996 C1172 C1180
6. 2 tension Proc Natl Acad Sci U S A 92 1995 5510 5514
7. Yu AY, Frid MG, Shimoda LA, Wiener CM, Stenmark K, Semenza GL. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol 275:L818-26.
8. G.L. Semenza Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 2003 721 732
9. R.K. Bruick Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia Proc Natl Acad Sci U S A 97 2000 9082 9087
10. H. Zhong, A.M. De Marzo, E. Laughner, M. Lim, D.A. Hilton, D. Zagzag, P. Buechler, W.B. Isaacs, G.L. Semenza, and J.W. Simons Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases Cancer Res 59 1999 5830 5835
11. R. Bos, H. Zhong, C.F. Hanrahan, E.C. Mommers, G.L. Semenza, H.M. Pinedo, M.D. Abeloff, J.W. Simons, P.J. van Diest, and W.E. van der Levels of hypoxia-inducible factor-1α during breast carcinogenesis J Natl Cancer Inst 93 2001 309 314
12. R. Bos, G.P. van der, A.E. Greijer, A. Shvarts, S. Meijer, H.M. Pinedo, G.L. Semenza, P.J. van Diest, and W.E. van der Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma Cancer 97 2003 1573 1581
13. G. Gruber, R.H. Greiner, R. Hlushchuk, D.M. Aebersold, H.J. Altermatt, G. Berclaz, and V. Djonov Hypoxia-inducible factor 1α in high-risk breast cancer: an independent prognostic parameter? Breast Cancer Res 6 2004 R191 R198
14. M. Schindl, S.F. Schoppmann, H. Samonigg, H. Hausmaninger, W. Kwasny, M. Gnant, R. Jakesz, E. Kubista, P. Birner, G. Oberhuber Austrian Breast and Colorectal Cancer Study Group Overexpression of hypoxia-inducible factor 1α is associated with an unfavorable prognosis in lymph node-positive breast cancer Clin Cancer Res 8 2002 1831 1837
15. M.M. Vleugel, A.E. Greijer, A. Shvarts, P. Van der Groep, M. Van Berkel, Y. Aarbodem, H. Van Tinteren, P.J. Van Diest, and E. Van der Wall Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancer J Clin Pathol 58 2005 172 177
16. 2-regulated prolyl hydroxylation Science 292 2001 468 472
17. K. Tanimoto, Y. Makino, T. Pereira, and L. Poellinger Mechanism of regulation of the hypoxia-inducible factor-1α by the Von Hippel-Lindau tumor suppressor protein EMBO J 19 2000 4298 4309
18. N. Sang, J. Fang, V. Srinivas, I. Leshchinsky, and J. Caro Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1α is governed by a Von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP Mol Cell Biol 22 2002 2984 2992
19. 2-dependent degradation domain via the ubiquitin-proteasome pathway Proc Natl Acad Sci U S A 95 1998 7987 7992
20. C.H. Sutter, E. Laughner, and G.L. Semenza Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations Proc Natl Acad Sci U S A 97 2000 4748 4753
21. 2-dependent degradation domain of hypoxia inducible factor-1α (HIF-1α) J Cancer Res Clin Oncol 128 2002 358 362
22. X.S. Fu, E. Choi, G.J. Bubley, and S.P. Balk Identification of hypoxia-inducible factor-1α (HIF-1α) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation Prostate 63 2005 215 221 [Epub Nov. 10, 2004]
23. M.J. Percy, S.M. Mooney, M.F. McMullin, A. Flores, T.R. Lappin, and F.S. Lee A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1α (HIF-1α) does not impair Pro-564 hydroxylation Mol Cancer 2 2003 31
24. K. Tanimoto, K. Yoshiga, H. Eguchi, M. Kaneyasu, K. Ukon, T. Kumazaki, N. Oue, W. Yasui, K. Imai, K. Nakachi, L. Poellinger, and M. Nishiyama Hypoxia-inducible factor-1α polymorphisms associated with enhanced transactivation capacity, implying clinical significance Carcinogenesis 24 2003 1779 1783
25. S.C. Clifford, D. Astuti, L. Hooper, P.H. Maxwell, P.J. Ratcliffe, and E.R. Maher The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinoma Oncogene 20 2001 5067 5074
26. M. Ollerenshaw, T. Page, J. Hammonds, and A. Demaine Polymorphisms in the hypoxia inducible factor-1α gene (HIF1A) are associated with the renal cell carcinoma phenotype Cancer Genet Cytogenet 153 2004 122 126
27. T. Kuwai, Y. Kitadai, S. Tanaka, T. Kuroda, T. Ochiumi, S. Matsumura, N. Oue, W. Yasui, M. Kaneyasu, K. Tanimoto, M. Nishiyama, and K. Chayama Single nucleotide polymorphism in the hypoxia-inducible factor-1α gene in colorectal carcinoma Oncol Rep 12 2004 1033 1037
28. M.M. Weiss, M.A. Hermsen, G.A. Meijer, N.C. Van Grieken, J.P. Baak, E.J. Kuipers, and P.J. Van Diest Comparative genomic hybridisation Mol Pathol 52 1999 243 251
29. O.R. Saramaki, K.J. Savinainen, N.N. Nupponen, O. Bratt, and T. Visakorpi Amplification of hypoxia-inducible factor 1α gene in prostate cancer Cancer Genet Cytogenet 128 2001 31 34
30. E. Laughner, P. Taghavi, K. Chiles, P.C. Mahon, and G.L. Semenza HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression Mol Cell Biol 21 2001 3995 4004
31. M.M. Vleugel, R. Bos, P. Van der Groep, O. Säramaki, T. Visakorpi, E. Wall van der, and P.J. Van Diest No amplifications of hypoxia-inducible factor-1 gene in invasive breast cancer: a tissue microarray study Cellular Oncol 26 5-6 2004 347 351
32. G.L. Wang, and G.L. Semenza Purification and characterization of hypoxia-inducible factor 1 J Biol Chem 270 1995 1230 1237
33. S. Rogers, R. Wells, and M. Rechsteiner Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis Science 234 1986 364 368